Cargando…

Basal insulin initiation in primary vs. specialist care: similar glycaemic control in two different patient populations

OBJECTIVE: To investigate the effect of healthcare provider (HCP) type (primary vs. specialist) on glycaemic control and other treatment parameters. RESEARCH DESIGN AND METHODS: Study of Once‐Daily Levemir (SOLVE (™)) is an international, 24‐week, observational study of insulin initiation in people...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orozco‐Beltran, D., Pan, C., Svendsen, A. L., Færch, L., Caputo, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Endocrinology and Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832583/ https://www.ncbi.nlm.nih.gov/pubmed/26916450 http://dx.doi.org/10.1111/ijcp.12776

Ejemplares similares

When glycaemic targets can no longer be achieved with basal insulin in type 2 diabetes, can simple intensification with a modern premixed insulin help? Results from a subanalysis of the PRESENT study
por: Jang, H C, et al.
Publicado: (2008)

Primary care physician beliefs about insulin initiation in patients with type 2 diabetes
por: Hayes, R P, et al.
Publicado: (2008)

Older type 2 diabetic patients are more likely to achieve glycaemic and cardiovascular risk factors targets than younger patients: analysis of a primary care database
por: Barrot‐de la Puente, J., et al.
Publicado: (2015)

Practical guidance on the initiation, titration, and switching of basal insulins: a narrative review for primary care
por: Mehta, Roopa, et al.
Publicado: (2021)

Impact of Pocket Insulin Dosing Guide on Utilization of Basal/Bolus Insulin by Internal Medicine Resident Physicians
por: Mamillapalli, Chaitanya K, et al.
Publicado: (2018)

Plasmapheresis vs Conventional Insulin Therapy in Hypertriglyceridemia-Induced Acute Pancreatitis
por: Orabueze, Ijeoma, et al.
Publicado: (2023)

The Clinical Impact of Switching Basal Insulin to Insulin Degludec in Patients With Diabetes in Saudi Arabia: A Retrospective One-Group Pretest-Posttest Design Study
por: Althagafi, Abdulhamid, et al.
Publicado: (2022)

Association of Plasma Neurofilament Light Chain With Glycaemic Control and Insulin Resistance in Middle-Aged Adults
por: Thota, Rohith N., et al.
Publicado: (2022)

The Impact of Flash Glucose Monitoring on Markers of Glycaemic Control and Patient Satisfaction in Type 2 Diabetes
por: Al Hayek, Ayman, et al.
Publicado: (2021)

Diabetic Striatopathy: A Case Report of a Patient With Poor Glycaemic Control and Abnormal Movements
por: Chithrapathra, Kasun E, et al.
Publicado: (2023)

Basal and Insulin Mediated VLDL-Triglyceride Kinetics in Type 2 Diabetic Men
por: Sørensen, Lars P., et al.
Publicado: (2011)

Comparison of Human Premixed and Basal Plus Short-Acting Insulin Regimens for Individuals With Type 2 Diabetes During Ramadan Fasting
por: Altemimi, Mahmood Thamer, et al.
Publicado: (2020)

How much is too much? Outcomes in patients using high‐dose insulin glargine
por: Reid, T., et al.
Publicado: (2015)

Inpatient Glycaemic Control is Poor in Patients Receiving Insulin Therapy
por: Reidy, Niall, et al.
Publicado: (2021)

Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA
por: Mauricio, Dídac, et al.
Publicado: (2017)

Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo
por: Gao, Y, et al.
Publicado: (2015)

Acute Administration of Unacylated Ghrelin Has No Effect on Basal or Stimulated Insulin Secretion in Healthy Humans
por: Tong, Jenny, et al.
Publicado: (2014)

Novel PEGylated Basal Insulin LY2605541 Has a Preferential Hepatic Effect on Glucose Metabolism
por: Moore, Mary Courtney, et al.
Publicado: (2014)

Low basal metabolic rate as a risk factor for development of insulin resistance and type 2 diabetes
por: Maciak, Sebastian, et al.
Publicado: (2020)

Cost of severe hypoglycaemia in patients with type 1 diabetes in Spain and the cost-effectiveness of insulin lispro compared with regular human insulin in preventing severe hypoglycaemia
por: Reviriego, J, et al.
Publicado: (2008)

Successful Resolution of Glucose Toxicity With the Use of Fixed-Ratio Combination Injection of Basal Insulin and Short-Acting Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist
por: Miura, Hiroshi, et al.
Publicado: (2022)

Seizures and Basal Ganglia Calcification Caused by Hypoparathyroidism
por: Nageen, Tabinda, et al.
Publicado: (2020)

Protocol for a randomised controlled trial of the effect of dapagliflozin, metformin and exercise on glycaemic variability, body composition and cardiovascular risk in prediabetes (the PRE-D Trial)
por: Færch, Kristine, et al.
Publicado: (2017)

COVID-19 and Pre-existing Type 2 Diabetes Mellitus: A Retrospective Observational Study From Eastern India on the Association Between Glycaemic Control and Treatment Outcomes
por: Mukherjee, Poulomi, et al.
Publicado: (2023)

Low-glycaemic index diet to improve glycaemic control and cardiovascular disease in type 2 diabetes: design and methods for a randomised, controlled, clinical trial
por: Chiavaroli, Laura, et al.
Publicado: (2016)

Insulin Edema With Use of U-500 Regular Insulin in a Hybrid Closed-Loop Insulin Pump
por: Vasigh, Mostafa, et al.
Publicado: (2020)

Faster Insulin Aspart for Continuous Subcutaneous Insulin Infusion: Is It Worth It?
por: Rosinha, Patrícia, et al.
Publicado: (2022)

Comparison of the Effect of Glycemic Control in Type 2 Diabetes Outpatients Treated With Premixed and Basal Insulin Monotherapy in China
por: Liu, Guangxu, et al.
Publicado: (2018)

PSUN181 Diabetes-related outcomes following use of basal-bolus insulin vs. premixed insulin in a VA population with Type 2 diabetes: A retrospective chart review.
por: Izuora, Kenneth, et al.
Publicado: (2022)

LBSUN319 Characteristics And Treatment Patterns Of Hispanic/latino Patients Initiating First Injectable Glp-1ra Or Basal Insulin
por: Hoog, Meredith, et al.
Publicado: (2022)

FRI638 Glycemic And Cost Outcomes In Hispanic/Latino People With Type 2 Diabetes Initiating Dulaglutide Or Basal Insulin In The US
por: Hoog, Meredith, et al.
Publicado: (2023)

A Case of a Second Intermetatarsal Space Gouty Tophus with a Presentation Similar to a Morton’s Neuroma
por: Razaghi, Fatemeh, et al.
Publicado: (2018)

Study protocol for optimising glycaemic control in type 1 diabetes treated with multiple daily insulin injections: intermittently scanned continuous glucose monitoring, carbohydrate counting with automated bolus calculation, or both? A randomised controlled trial
por: Secher, Anna Lilja, et al.
Publicado: (2020)

Hypoglycemia-Induced Basal Ganglia Infarct: A Rare Case of Metformin Toxicity in a Hemodialysis Patient
por: Collins, Rovena, et al.
Publicado: (2022)

Glycaemic control and novel technology management strategies in pregestational diabetes mellitus
por: Newman, Christine, et al.
Publicado: (2023)

A Non-obese, Treatment-Naive Japanese Diabetic Patient With Elevated Insulin Clearance and Hyperglycemia Under Enhanced Insulin Sensitivity and Increased Insulin Secretion: Elevated Insulin Clearance as Type 2 Japanese Diabetes Mellitus (T2JDM)
por: Sugiyama, Seigo, et al.
Publicado: (2021)

A Review of the Impact of Smoking on Inhaled Insulin: Would You Stop Smoking if Insulin Can Be Inhaled?
por: Malhotra, Parul, et al.
Publicado: (2020)

Factitious Hypoglycemia in an Infant With Undetectable Exogenous Insulin by a Commercial Insulin Immunoassay: A Diagnostic Pitfall
por: Arabi, Hisham, et al.
Publicado: (2023)

Clinical effectiveness of liraglutide vs basal insulin in a real‐world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes
por: Overbeek, Jetty A., et al.
Publicado: (2018)

Modulation of Glucose Production by Central Insulin Requires IGF-1 Receptors in AgRP Neurons
por: Farias Quipildor, Gabriela, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mrpk78gddv5sqn7l0kta1oligd